-
Medical journals
- Career
Clinical Oncology - Issue 5/2024
Editorial
319
Reviews
324The dyslipidemic effect of cytostatics in the treatment of early breast cancer as a serious risk factor of cardiovascular diseasesL. Rušinová, M. Kozárová, Z. Kozelová, M. Valíková-Bavoľárová
331
Original Articles
335Accelerated radiotherapy in the treatment of anal squamous cell carcinoma – a single institution retrospective evaluationZ. Pechačová, R. Lohynská, Š. Šantrůčková, A. Šubrt, T. Drbohlavová, M. Pála
345Analysis of metalothionein in patients with malignant liver tumorsL. Melich, J. Werle, M. Fořtová, L. Vysloužilová, K. Burešová, K. Kotaška, E. Klapková, O. Štěpánková, J. Čepová, R. Průša, R. Kizek
Case Reports
354Treatment of retroperitoneal fibrosis with rituximab, cyclophosphamide and dexamethasone, followed by rituximab and dexamethasone maintenance, achieved disappearance of pathological PET accumulation of FDG and regression of fibrotic masses after 4 months of therapy and the patient is still in complete remission after 3 years. A case report and iteraure review.A. Čermák, J. Foukal, Z. Řehák, Z. Adam, M. Keřkovský, L. Hruška, M. Borský, M. Doubek, J. Vlažný, Z. Pavlovský, Z. Chovancová, I. Boichuk, M. Štork, L. Pour, R. Koukalová, M. Tomíška, Z. Král
370Total neoadjuvant therapy involving checkpoint inhibitors in locally advanced MSI/dMMR rectal cancer – a case reportS. Křivonosková, A. Opluštilová, M. Levý, M. Komár, B. Rosová, R. Lohynská, L. Boublíková
375Long-term control by immune checkpoint inhibitors in a lung cancer patient with chronic kidney diseaseH. Matsumoto, Y. Maezawa, G. Ohara, T. Shiozawa, H. Masuko, H. Satoh
380Viral pneumonia in a patient treated with pembrolizumab – similarity with immune-related pneumonitisJ. Podhorec, L. Jakubíková, O. Bílek, I. Kiss, A. Poprach
Short Communication
384The guidelines for clinical practice for carriers of germline mutations in the Lynch syndrome predisposition genes MLH1, MSH2, MSH6, PMS2 and large deletions of EPCAM (4.2024)J. Novotný, D. Cibula, V. Curtisová, O. Dubová, L. Foretová, A. Germanová, M. Janatová, O. Havránek, M. Hojsáková, M. Hudcová, M. Koudová, V. Krutílková, M. Palacova, S. Paulich, K. Petrakova, J. Presl, A. Puchmajerová, J. Soukupová, M. Šenkeříková, Z. Šimková, H. Štěpánková, I. Šubrt, I. Tachecí, P. Tesner, O. Urban, K. Veselá, Š. Vilímová, Z. Vlčková, M. Vočka, V. Weinberger, M. Zikán, M. Zimovjanová, Z. Kleibl, P. Kleiblová
Reports from the literature
391
Personal News
Clinical Oncology
2024 Issue 5
Most read in this issue- The guidelines for clinical practice for carriers of germline mutations in the Lynch syndrome predisposition genes MLH1, MSH2, MSH6, PMS2 and large deletions of EPCAM (4.2024)
- Gemcitabine/nab-paclitaxel in first line treatment of advanced pancreatic cancer – head-to-head comparison with the mFOLFIRINOX regimen
- Treatment of retroperitoneal fibrosis with rituximab, cyclophosphamide and dexamethasone, followed by rituximab and dexamethasone maintenance, achieved disappearance of pathological PET accumulation of FDG and regression of fibrotic masses after 4 months of therapy and the patient is still in complete remission after 3 years. A case report and iteraure review.
- Viral pneumonia in a patient treated with pembrolizumab – similarity with immune-related pneumonitis
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career